These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38373395)

  • 1. Unraveling Dravet Syndrome: Exploring the complex effects of sodium channel mutations on neuronal networks.
    Doorn N
    Sci Prog; 2024; 107(1):368504231225076. PubMed ID: 38373395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome.
    Rubinstein M; Westenbroek RE; Yu FH; Jones CJ; Scheuer T; Catterall WA
    Neurobiol Dis; 2015 Jan; 73():106-17. PubMed ID: 25281316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism.
    Liu Y; Lopez-Santiago LF; Yuan Y; Jones JM; Zhang H; O'Malley HA; Patino GA; O'Brien JE; Rusconi R; Gupta A; Thompson RC; Natowicz MR; Meisler MH; Isom LL; Parent JM
    Ann Neurol; 2013 Jul; 74(1):128-39. PubMed ID: 23821540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dravet syndrome and its mimics: Beyond SCN1A.
    Steel D; Symonds JD; Zuberi SM; Brunklaus A
    Epilepsia; 2017 Nov; 58(11):1807-1816. PubMed ID: 28880996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCN1A-deficient excitatory neuronal networks display mutation-specific phenotypes.
    van Hugte EJH; Lewerissa EI; Wu KM; Scheefhals N; Parodi G; van Voorst TW; Puvogel S; Kogo N; Keller JM; Frega M; Schubert D; Schelhaas HJ; Verhoeven J; Majoie M; van Bokhoven H; Nadif Kasri N
    Brain; 2023 Dec; 146(12):5153-5167. PubMed ID: 37467479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dravet syndrome and Dravet syndrome-like phenotype: a systematic review of the SCN1A and PCDH19 variants.
    Rampazzo ACM; Dos Santos RRP; Maluf FA; Simm RF; Marson FAL; Ortega MM; de Aguiar PHP
    Neurogenetics; 2021 May; 22(2):105-115. PubMed ID: 33937968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
    Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S
    Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
    Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
    Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients.
    Sun Y; Paşca SP; Portmann T; Goold C; Worringer KA; Guan W; Chan KC; Gai H; Vogt D; Chen YJ; Mao R; Chan K; Rubenstein JL; Madison DV; Hallmayer J; Froehlich-Santino WM; Bernstein JA; Dolmetsch RE
    Elife; 2016 Jul; 5():. PubMed ID: 27458797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
    PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From focal epilepsy to Dravet syndrome--Heterogeneity of the phenotype due to SCN1A mutations of the p.Arg1596 amino acid residue in the Nav1.1 subunit.
    Hoffman-Zacharska D; Szczepanik E; Terczynska I; Goszczanska-Ciuchta A; Zalewska-Miszkurka Z; Tataj R; Bal J
    Neurol Neurochir Pol; 2015; 49(4):258-66. PubMed ID: 26188943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy.
    Voskobiynyk Y; Battu G; Felker SA; Cochran JN; Newton MP; Lambert LJ; Kesterson RA; Myers RM; Cooper GM; Roberson ED; Barsh GS
    PLoS Genet; 2021 Jan; 17(1):e1009195. PubMed ID: 33411788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
    Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
    J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in silico and in vitro human neuronal network model reveals cellular mechanisms beyond Na
    Doorn N; van Hugte EJH; Ciptasari U; Mordelt A; Meijer HGE; Schubert D; Frega M; Nadif Kasri N; van Putten MJAM
    Stem Cell Reports; 2023 Aug; 18(8):1686-1700. PubMed ID: 37419110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy.
    Wang JW; Shi XY; Kurahashi H; Hwang SK; Ishii A; Higurashi N; Kaneko S; Hirose S;
    Epilepsy Res; 2012 Dec; 102(3):195-200. PubMed ID: 23195492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.
    Schutte RJ; Schutte SS; Algara J; Barragan EV; Gilligan J; Staber C; Savva YA; Smith MA; Reenan R; O'Dowd DK
    J Neurophysiol; 2014 Aug; 112(4):903-12. PubMed ID: 24805083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome.
    Niibori Y; Lee SJ; Minassian BA; Hampson DR
    Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dravet syndrome: a genetic epileptic disorder.
    Akiyama M; Kobayashi K; Ohtsuka Y
    Acta Med Okayama; 2012; 66(5):369-76. PubMed ID: 23093055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet Syndrome.
    Weuring WJ; Singh S; Volkers L; Rook MB; van 't Slot RH; Bosma M; Inserra M; Vetter I; Verhoeven-Duif NM; Braun KPJ; Rivara M; Koeleman BPC
    PLoS One; 2020; 15(3):e0219106. PubMed ID: 32134913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication.
    Matricardi S; Cestèle S; Trivisano M; Kassabian B; Leroudier N; Vittorini R; Nosadini M; Cesaroni E; Siliquini S; Marinaccio C; Longaretti F; Podestà B; Operto FF; Luisi C; Sartori S; Boniver C; Specchio N; Vigevano F; Marini C; Mantegazza M
    Epilepsia; 2023 May; 64(5):1331-1347. PubMed ID: 36636894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.